Patents by Inventor William Yelle

William Yelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • S-lansoprazole compositions and methods
    Publication number: 20060142346
    Abstract: Methods and compositions are disclosed utilizing optically pure (?) lansoprazole for the treatment of ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of lansoprazole. The optically pure (?) isomer is also useful for the treatment of gastroesophageal reflux. (?) Lansoprazole is an inhibitor of H+ release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
    Type: Application
    Filed: February 22, 2006
    Publication date: June 29, 2006
    Inventors: Timothy Barberich, William Yelle, Paul Rubin
  • Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites
    Publication number: 20060019970
    Abstract: The invention relates to novel methods using, and pharmaceutical compositions comprising, ziprasidone metabolites. The methods and compositions of the invention are suitable for the treatment of neuroleptic and related disorders. The invention further encompasses methods of preparing ziprasidone sulfoxide and ziprasidone sulfone.
    Type: Application
    Filed: July 11, 2005
    Publication date: January 26, 2006
    Inventors: Timothy Barberich, Paul Rubin, William Yelle
  • S(-)rabeprazole compositions and methods
    Publication number: 20050222211
    Abstract: Methods and compositions are disclosed utilizing optically pure S(?)rabeprazole for the treatment of ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of rabeprazole. The optically pure S(?) isomer is also useful for the treatment of gastroesophageal reflux. S(?)rabeprazole is an inhibitor of H+ release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.
    Type: Application
    Filed: May 27, 2005
    Publication date: October 6, 2005
    Applicant: Sepracor Inc.
    Inventors: Patrick Koch, Paul Rubin, William Yelle